Pioneering Theranostic Advancements
Providing Radiopharmaceutical & Theranostic solutions across the ASEAN market.
How Theranostic work
Personalized medicine for a precise treatment. Theranostic care is a rapidly revolving field that combines the diagnostic imaging with the targeted therapy.
Diagnose
A theranostic agent is administered to the patient. Surely the agent varies patient to patient.
Imaging
The agent binds to the targeted biomarker, allowing the healthcare professionals to identify and asses the diseases to the molecular level.
Our Specialists Team
MED I (Thailand) has assembled a team of specialists whose contribution to the field of Radio Pharmaceuticals is immense. Their expertise manifests in facility design, project planning, equipment sourcing to service. MED I ( Thailand) covers all aspects of the trade and creates value for its collaborating customers.
J. Paul Shea, PhD
○ PhD Medicinal Chemist
○ 20+ years experience in Pharmaceutical Discovery and Development (Bristol-Myers Squibb, Biotechnology, CRO)
○ 20 years experience in PET imaging
○ VP Clinical Research,PETNet Solutions (Siemens)
○ VP Regulatory Affairs, CTI Molecular Imaging (Siemens)
○ Active in the PET Research Community
Salman Milibari
○ BS Nuclear Engineering
○ 35+ years experience in Cyclotron Operation
○ 20+ years Head Cyclotron Section, King Faisal Specialist Hospital, Riyadh
○ 25+ years Advisor to the International Atomic Energy Agency (IAEA) on Accelerator Safety
○ Certified by KSA National Center for Radiation Protection, 2018
John P. Doumitt, PE
○ BS Professional Engineer, Industrial Engineering
○ MS Management, Purdue University
○ 20+ years experience in PET GMP Facility Design, Construction Management, Logistics and General Operations
○ Logistics Manager, Director of Field Operations for Syncor (Cardinal Health)
○ Led $15M Operations upgrade program for IBA Molecular to meet new FDA-mandated GMP standards
○ Advised global Contract Research Organization (CRO) in the design and construction of Pre-clinical
Farhad Karimi, PhD
○ Vice President Radiochemistry and Regulatory Affairs in Luminare Molecular
○ PhD Organic Radiochemist, Uppsala University, IMANET PET Center
○ 20+ years of experience in the GMP production of PET tracers.
○ Operated GMP PET production sites in the US (Harvard University) and Australia (ANSTO)
○ Industry leading Strong Research background in novel 18F, 11C and 68Ga tracers.
Nicola Ceccomancini
○ Ex Managing Director of Cyclomedical East Africa Ltd.
○ Former Founder & CEO of A.R.T – Advanced Radioisotopes Technologies, Italy.
○ 20+ years of experience in Radiopharmaceuticals.
○ Excellent understanding and interpretation of regulatory and quality issues within corporate business activities
○ Consulted on over 50 radiopharmaceutical projects, ensuring safe and efficient operations.
Cristian-Neniscu
○ 15+ years of experience in Radiopharmaceutical industry as maintenance Manager for IBA molecular, Italy.
○ Specialist in facility maintenance and regulatory requirement.
○ Advisor for Ammo imaging Ltd.
○ Excellent understanding and interpretation of validation process in FAT, SAT, IQ, OQ, PQ protocols.
○ Provided technical service and solution on over 150+ cyclotron systems.
Solution We Provide
We provide solution in the whole theranostic care. From Facility design to right equipment supply we covered it all.
Events and Sponsor
Unlock the Secrets of Nuclear Medicine!
Dive into the world of innovation with our exclusive newsletter..
Subscribe now and be part of a community that’s shaping the future of healthcare. Don’t miss out on the opportunity to be informed, inspired, and involved.